Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
460-03-005 ISMRM Abstract

A longitudinal model based on td-dMRI-derived parameters for predicting neoadjuvant therapy response in breast cancer

Primary: Body - Breast
Secondary: Diffusion - Microstructure
460-03-005 · Image Classification for Breast Cancer · Tuesday, 12 May, 1:40 PM–2:35 PM · Digital Posters Row A
Accepted
Mingyue Yang 1, Siyao Du2,3, Ruimeng Zhao3, Thorsten Feiweier4,5,6,7,8,9,10,11,12,13,14,15,16,17,18, Yueluan Jiang19, LINA ZHANG1,20
1Department of Radiology, the Fourth Affiliated Hospital of China Medical University, Shenyang, China
2The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China, China
3Department of Radiology, Department of radiology, The First Hospital of China Medical University, Shenyang, China
4Siemens Healthineers AG, Erlangen, Germany
5Siemens Healthineers AG, Forchheim, Germany
6Siemens Healthcare GmbH, Erlangen, Germany
7Neurology Applications Development, Siemens Healthcare GmbH, Erlangen, Germany
8MR Research and Clinical Translation, Siemens Healthineers AG, Erlangen, Germany
9MR Research & Clinical Translation, Erlangen, Germany
10Research & Clinical Translation, Magnetic Resonance, Siemens Healthineers AG, Erlangen, Germany
11MR Research & Clinical Translation, Siemens Healthineers AG, Erlangen, Germany
12Research & Clinical Translation, Magnetic Resonance, Siemens Healthineers AG, Erlangen, Germany
13MR Application Predevelopment, Siemens Healthineers AG, Forchheim, Germany
14Research & Clinical Translation, Magnetic Resonance, Siemens Healthineers AG, Erlangen, Germany
15Magnetic Resonance, Siemens Healthineers AG, Erlangen, Germany
16Magnetic Resonance, Siemens Healthineers AG, Erlangen, Germany
17MR Research and Clinical Translation, Siemens Healthineers AG, Erlangen, Germany
18MR Research & Clinical Translation, Siemens Healthineers AG, Erlangen, Germany
19MR Research Collaboration Team, Siemens Healthineers Ltd., Beijing, China
20the Fourth Affiliated Hospital of China Medical University, Shenyang, China
Presenting Author: Mingyue Yang

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. 1.Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17. Erratum in: CA Cancer J Clin. 2024 Mar-Apr;74(2):203. doi: 10.3322/caac.21830. PMID: 38230766. [doi] [pmid]
2. Wang X, Ba R, Huang Y, Cao Y, Chen H, Xu H, Shen H, Liu D, Huang H, Yin T, Wu D, Zhang J. Time-Dependent Diffusion MRI Helps Predict Molecular Subtypes and Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer. Radiology. 2024 Oct;313(1):e240288. doi: 10.1148/radiol.240288. PMID: 39436292.. [doi] [pmid]
3. Prakash J, Shaked Y. The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics. Cancer Discov. 2024 Aug 2;14(8):1375-1388. doi: 10.1158/2159-8290.CD-24-000 . PMID: 39091205; PMCID: PMC11294818. [doi] [pmid]
4. Kang HS, Kim JY, Kim JJ, Kim S, Lee NK, Lee JW, Suh HB, Hwangbo L, Son Y, Grimm R. Diffusion Kurtosis MR Imaging of Invasive Breast Cancer: Correlations With Prognostic Factors and Molecular Subtypes. J Magn Reson Imaging. 2022 Jul;56(1):110-120. doi: 10.1002/jmri.27999IF: 3.5 Q1 . Epub 2021 Nov 18. PMID: 34792837. [doi] [pmid]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/460-03-005